Literature DB >> 27542429

Cancer Screening in Older Adults.

Ashley H Snyder1, Allison Magnuson2, Amy M Westcott3.   

Abstract

When screening for cancer in older adults, it is important to consider the risks of screening, how long it takes to benefit from screening, and the patient's comorbidities and life expectancy. Delivering high-value care requires the consideration of evidence-based screening guidelines and careful selection of patients. This article considers the impact of cancer. It explores perspectives on the costs of common cancer screening tests, illustrates how using life expectancy can help clinicians determine who will benefit most from screening, and provides tools to help clinicians discuss with their older patients when it may be appropriate to stop screening for cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer screening guidelines; Cost; Elderly; High-value care; Life expectancy; Older adult

Mesh:

Year:  2016        PMID: 27542429     DOI: 10.1016/j.mcna.2016.04.016

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  2 in total

1.  Metastasis Patterns and Prognosis of Octogenarians with NSCLC: A Population-based Study.

Authors:  Yu Gu; Junhua Zhang; Zhirui Zhou; Di Liu; Hongcheng Zhu; Junmiao Wen; Xinyan Xu; Tianxiang Chen; Min Fan
Journal:  Aging Dis       Date:  2020-02-01       Impact factor: 6.745

2.  Prediction of overall survival of non-small cell lung cancer with bone metastasis: an analysis of the Surveillance, Epidemiology and End Results (SEER) database.

Authors:  Si Shi; Hongwei Wang; Xiaohui Liu; Jinling Xiao
Journal:  Transl Cancer Res       Date:  2021-12       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.